WallStSmart
ATOS

Atossa Genetics Inc

NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY

$5.37
+1.70% today

Updated 2026-04-30

Market cap
$49.09M
P/E ratio
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
52W range
$4 – $19
Volume
0.1M

Atossa Genetics Inc (ATOS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+12.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-12.9%
2026-03-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$0.00+100.0%$5.26$5.37+2.0%
2026-03-26$-1.34-17.2%$5.42$4.72-12.9%
2025-11-12$-0.07-16.7%$0.83$0.80-3.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.07$0.00+100.0%
2025-12-31$-1.14$-1.34-17.2%
2025-09-30$-0.06$-0.07-16.7%
2025-06-30$-0.06$-0.07-16.7%
2025-03-31$-0.07$-0.05+28.6%
2024-12-31$-0.06$-0.05+21.0%
2024-09-30$-0.06$-0.06+4.2%
2024-06-30$-0.06$-0.05+16.7%
2024-03-31$-0.07$-0.05+28.6%$18000.00
2023-12-31$-0.06$-0.09-50.0%
2023-09-30$-0.07$-0.05+28.6%

Frequently asked questions

Has Atossa Genetics Inc beaten earnings estimates?
Atossa Genetics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +12.4% over the last 4 quarters.
How does ATOS stock react to earnings?
ATOS stock has moved an average of -4.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.